Can Psychiatry “Re-Engage” with Pharma?

On August 1, Jeffrey Lieberman, M.D., the current President of the American Psychiatric Association,  wrote an open letter to Psychiatry News asking whether is was time for psychiatry to “re-engage with pharma”. Dr. Lieberman asserts that although there are problems with the way the public perceives drug companies, he thinks it is time for psychiatry to re-evaluate […]